The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus
Abstract
A new, competitive, nonpeptide cholecystokinin (CCK) antagonist, asperlicin, was isolated from the fungus Aspergillus alliaceus. The compound has 300 to 400 times the affinity for pancreatic, ileal, and gallbladder CCK receptors than proglumide, a standard agent of this class. Moreover, asperlicin is highly selective for peripheral CCK receptors relative to brain CCK and gastrin receptors. Since asperlicin also exhibits long-lasting CCK antagonist activity in vivo, it should provide a valuable tool for investigating the physiological and pharmacological actions of CCK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,778
Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding
Braestrup, C., & Squires, R. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3805 · Cited by 1,264
Distinct cholecystokinin receptors in brain and pancreas.
Innis, R. B., & Snyder, S. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6917 · Cited by 573
Brain Peptides: What, Where, And Why?
Krieger, D. T. (1983) · Science · doi:10.1126/science.6139875 · Cited by 474
Le Fur, G., Perrier, M. L., Vaucher, N., Imbault, F., Flamier, A., Benavides, J., Uzan, A., Renault, C., Dubroeucq, M. C., & Guérémy, C. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90062-0 · Cited by 345
The ascent of cholecystokinin (CCK) — From gut to brain
Morley, J. E. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90261-2 · Cited by 245
Chang, R. S. L., Lotti, V. J., Martin, G. E., & Chen, T. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90224-2 · Cited by 88
Self-citation
Cited by
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
Horton, D. A., Bourne, G. T., & Smythe, M. L. (2003) · Chemical Reviews · doi:10.1021/cr020033s · Cited by 3,013
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199312441 · Cited by 784
Biological actions of cholecystokinin
Crawley, J. N., & Corwin, R. L. (1994) · Peptides · doi:10.1016/0196-9781(94)90104-x · Cited by 712
Chang, R. S., & Lotti, V. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4923 · Cited by 540
Self-citationNatural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
Lotti, V. J., & Chang, R. S. L. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90290-2 · Cited by 398
Self-citationNoble, F., Wank, S. A., Crawley, J. N., Bradwejn, J., Seroogy, K. B., Hamon, M., & Roques, B. P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01427-3 · Cited by 384
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
Evans, B. E., Bock, M. G., Rittle, K. E., DiPardo, R. M., Whitter, W. L., Veber, D. F., Anderson, P. S., & Freidinger, R. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4918 · Cited by 327
Chapter 26. Privileged structures — An update
Patchett, A. A., & Nargund, R. P. (2000) · Annual Reports in Medicinal Chemistry · doi:10.1016/s0065-7743(00)35027-8 · Cited by 302
Self-citationStructural Simplification of Natural Products
Wang, S., Dong, G., & Sheng, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00504 · Cited by 254
Metadata
- Authors
- Chang, R., Lotti, V., Monaghan, R., Birnbaum, J., Stapley, E., Goetz, M., Albers-Schonberg, G., Patchett, A., Liesch, J., Hensens, O., & et, A.
- Venue
- Science
- Published
- 1985-10-11
- Volume
- 230
- Issue
- 4722
- Pages
- 177-179
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2038552915
- Cited by
- 319
- References
- 7
- FWCI
- 14.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.